Global Amyotrophic Lateral Sclerosis Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
The global Amyotrophic Lateral Sclerosis Drugs market size is projected to grow from US$ 293.5 million in 2023 to US$ 346.1 million in 2030; it is expected to grow at a CAGR of 2.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Amyotrophic Lateral Sclerosis Drugs Industry Forecast” looks at past sales and reviews total world Amyotrophic Lateral Sclerosis Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Amyotrophic Lateral Sclerosis Drugs sales for 2024 through 2030. With Amyotrophic Lateral Sclerosis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amyotrophic Lateral Sclerosis Drugs industry.
This Insight Report provides a comprehensive analysis of the global Amyotrophic Lateral Sclerosis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amyotrophic Lateral Sclerosis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amyotrophic Lateral Sclerosis Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amyotrophic Lateral Sclerosis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amyotrophic Lateral Sclerosis Drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Drugs market by product type, application, key players and key regions and countries.
Segmentation by type
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
The global Amyotrophic Lateral Sclerosis Drugs market size is projected to grow from US$ 293.5 million in 2023 to US$ 346.1 million in 2030; it is expected to grow at a CAGR of 2.4% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Amyotrophic Lateral Sclerosis Drugs Industry Forecast” looks at past sales and reviews total world Amyotrophic Lateral Sclerosis Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Amyotrophic Lateral Sclerosis Drugs sales for 2024 through 2030. With Amyotrophic Lateral Sclerosis Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amyotrophic Lateral Sclerosis Drugs industry.
This Insight Report provides a comprehensive analysis of the global Amyotrophic Lateral Sclerosis Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amyotrophic Lateral Sclerosis Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amyotrophic Lateral Sclerosis Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amyotrophic Lateral Sclerosis Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amyotrophic Lateral Sclerosis Drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of Amyotrophic Lateral Sclerosis Drugs market by product type, application, key players and key regions and countries.
Segmentation by type
- Riluzole
- Edaravone (Radicava)
- CoQ10
- Butylphthalide
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Mitsubishi Tanabe Pharma
- Mylan
- Apotex
- Glemark Generics
- Sun Pharma
- Covis Pharma
- Lunan Pharma
- CSPC Pharmaceutical
- Ascend Laboratories
- EISAI
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2030
2.1.2 Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Amyotrophic Lateral Sclerosis Drugs Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone (Radicava)
2.2.3 CoQ10
2.2.4 Butylphthalide
2.2.5 Others
2.3 Amyotrophic Lateral Sclerosis Drugs Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
2.4 Amyotrophic Lateral Sclerosis Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Amyotrophic Lateral Sclerosis Drugs Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
3 AMYOTROPHIC LATERAL SCLEROSIS DRUGS MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2019-2024)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS DRUGS BY REGIONS
4.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (2019-2024)
4.2 Americas Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
4.3 APAC Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
4.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2019-2024)
5.2 Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
5.3 Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2019-2024)
6.2 APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
6.3 APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Drugs by Country (2019-2024)
7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs by Region (2019-2024)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS DRUGS MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Regions (2025-2030)
10.1.1 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Amyotrophic Lateral Sclerosis Drugs Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Drugs Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Drugs Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Drugs Forecast by Country (2025-2030)
10.2.1 United States Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Drugs Forecast by Region (2025-2030)
10.3.1 China Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Drugs Forecast by Country (2025-2030)
10.4.1 Germany Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Type (2025-2030)
10.7 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Amyotrophic Lateral Sclerosis Drugs Product Offered
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Mitsubishi Tanabe Pharma
11.2.1 Mitsubishi Tanabe Pharma Company Information
11.2.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mitsubishi Tanabe Pharma Main Business Overview
11.2.5 Mitsubishi Tanabe Pharma Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Amyotrophic Lateral Sclerosis Drugs Product Offered
11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Amyotrophic Lateral Sclerosis Drugs Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Information
11.5.2 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Glemark Generics Main Business Overview
11.5.5 Glemark Generics Latest Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Company Information
11.6.2 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sun Pharma Main Business Overview
11.6.5 Sun Pharma Latest Developments
11.7 Covis Pharma
11.7.1 Covis Pharma Company Information
11.7.2 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Covis Pharma Main Business Overview
11.7.5 Covis Pharma Latest Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Information
11.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lunan Pharma Main Business Overview
11.8.5 Lunan Pharma Latest Developments
11.9 CSPC Pharmaceutical
11.9.1 CSPC Pharmaceutical Company Information
11.9.2 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Offered
11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CSPC Pharmaceutical Main Business Overview
11.9.5 CSPC Pharmaceutical Latest Developments
11.10 Ascend Laboratories
11.10.1 Ascend Laboratories Company Information
11.10.2 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Offered
11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ascend Laboratories Main Business Overview
11.10.5 Ascend Laboratories Latest Developments
11.11 EISAI
11.11.1 EISAI Company Information
11.11.2 EISAI Amyotrophic Lateral Sclerosis Drugs Product Offered
11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 EISAI Main Business Overview
11.11.5 EISAI Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2030
2.1.2 Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Amyotrophic Lateral Sclerosis Drugs Segment by Type
2.2.1 Riluzole
2.2.2 Edaravone (Radicava)
2.2.3 CoQ10
2.2.4 Butylphthalide
2.2.5 Others
2.3 Amyotrophic Lateral Sclerosis Drugs Market Size by Type
2.3.1 Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
2.4 Amyotrophic Lateral Sclerosis Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Amyotrophic Lateral Sclerosis Drugs Market Size by Application
2.5.1 Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
3 AMYOTROPHIC LATERAL SCLEROSIS DRUGS MARKET SIZE BY PLAYER
3.1 Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Players
3.1.1 Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2019-2024)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AMYOTROPHIC LATERAL SCLEROSIS DRUGS BY REGIONS
4.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (2019-2024)
4.2 Americas Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
4.3 APAC Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
4.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2019-2024)
5.2 Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
5.3 Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2019-2024)
6.2 APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
6.3 APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Drugs by Country (2019-2024)
7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs by Region (2019-2024)
8.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL AMYOTROPHIC LATERAL SCLEROSIS DRUGS MARKET FORECAST
10.1 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Regions (2025-2030)
10.1.1 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Amyotrophic Lateral Sclerosis Drugs Forecast
10.1.3 APAC Amyotrophic Lateral Sclerosis Drugs Forecast
10.1.4 Europe Amyotrophic Lateral Sclerosis Drugs Forecast
10.1.5 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Forecast
10.2 Americas Amyotrophic Lateral Sclerosis Drugs Forecast by Country (2025-2030)
10.2.1 United States Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.2.2 Canada Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.2.3 Mexico Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.2.4 Brazil Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3 APAC Amyotrophic Lateral Sclerosis Drugs Forecast by Region (2025-2030)
10.3.1 China Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.2 Japan Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.3 Korea Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.4 Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.5 India Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.3.6 Australia Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4 Europe Amyotrophic Lateral Sclerosis Drugs Forecast by Country (2025-2030)
10.4.1 Germany Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.2 France Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.3 UK Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.4 Italy Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.4.5 Russia Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.2 South Africa Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.3 Israel Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.4 Turkey Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.5.5 GCC Countries Amyotrophic Lateral Sclerosis Drugs Market Forecast
10.6 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Type (2025-2030)
10.7 Global Amyotrophic Lateral Sclerosis Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Amyotrophic Lateral Sclerosis Drugs Product Offered
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Mitsubishi Tanabe Pharma
11.2.1 Mitsubishi Tanabe Pharma Company Information
11.2.2 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mitsubishi Tanabe Pharma Main Business Overview
11.2.5 Mitsubishi Tanabe Pharma Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Amyotrophic Lateral Sclerosis Drugs Product Offered
11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Apotex
11.4.1 Apotex Company Information
11.4.2 Apotex Amyotrophic Lateral Sclerosis Drugs Product Offered
11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Apotex Main Business Overview
11.4.5 Apotex Latest Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Information
11.5.2 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Offered
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Glemark Generics Main Business Overview
11.5.5 Glemark Generics Latest Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Company Information
11.6.2 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sun Pharma Main Business Overview
11.6.5 Sun Pharma Latest Developments
11.7 Covis Pharma
11.7.1 Covis Pharma Company Information
11.7.2 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Covis Pharma Main Business Overview
11.7.5 Covis Pharma Latest Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Information
11.8.2 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Lunan Pharma Main Business Overview
11.8.5 Lunan Pharma Latest Developments
11.9 CSPC Pharmaceutical
11.9.1 CSPC Pharmaceutical Company Information
11.9.2 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Offered
11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 CSPC Pharmaceutical Main Business Overview
11.9.5 CSPC Pharmaceutical Latest Developments
11.10 Ascend Laboratories
11.10.1 Ascend Laboratories Company Information
11.10.2 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Offered
11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Ascend Laboratories Main Business Overview
11.10.5 Ascend Laboratories Latest Developments
11.11 EISAI
11.11.1 EISAI Company Information
11.11.2 EISAI Amyotrophic Lateral Sclerosis Drugs Product Offered
11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 EISAI Main Business Overview
11.11.5 EISAI Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone (Radicava)
Table 4. Major Players of CoQ10
Table 5. Major Players of Butylphthalide
Table 6. Major Players of Others
Table 7. Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 10. Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Player (2019-2024)
Table 15. Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Products Offered
Table 16. Amyotrophic Lateral Sclerosis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Drugs
Table 48. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Drugs
Table 49. Key Industry Trends of Amyotrophic Lateral Sclerosis Drugs
Table 50. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 55. Sanofi Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 56. Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Sanofi Main Business
Table 58. Sanofi Latest Developments
Table 59. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 60. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 61. Mitsubishi Tanabe Pharma Main Business
Table 62. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Mitsubishi Tanabe Pharma Latest Developments
Table 64. Mylan Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 65. Mylan Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 66. Mylan Main Business
Table 67. Mylan Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Mylan Latest Developments
Table 69. Apotex Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 70. Apotex Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 71. Apotex Main Business
Table 72. Apotex Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Apotex Latest Developments
Table 74. Glemark Generics Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 75. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 76. Glemark Generics Main Business
Table 77. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Glemark Generics Latest Developments
Table 79. Sun Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 80. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 81. Sun Pharma Main Business
Table 82. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Sun Pharma Latest Developments
Table 84. Covis Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 85. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 86. Covis Pharma Main Business
Table 87. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Covis Pharma Latest Developments
Table 89. Lunan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 90. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 91. Lunan Pharma Main Business
Table 92. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Lunan Pharma Latest Developments
Table 94. CSPC Pharmaceutical Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 95. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 96. CSPC Pharmaceutical Main Business
Table 97. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. CSPC Pharmaceutical Latest Developments
Table 99. Ascend Laboratories Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 100. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 101. Ascend Laboratories Main Business
Table 102. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Ascend Laboratories Latest Developments
Table 104. EISAI Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 105. EISAI Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 106. EISAI Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. EISAI Main Business
Table 108. EISAI Latest Developments
Table 1. Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Riluzole
Table 3. Major Players of Edaravone (Radicava)
Table 4. Major Players of CoQ10
Table 5. Major Players of Butylphthalide
Table 6. Major Players of Others
Table 7. Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 10. Amyotrophic Lateral Sclerosis Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Player (2019-2024)
Table 15. Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Products Offered
Table 16. Amyotrophic Lateral Sclerosis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Amyotrophic Lateral Sclerosis Drugs
Table 48. Key Market Challenges & Risks of Amyotrophic Lateral Sclerosis Drugs
Table 49. Key Industry Trends of Amyotrophic Lateral Sclerosis Drugs
Table 50. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Amyotrophic Lateral Sclerosis Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Sanofi Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 55. Sanofi Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 56. Sanofi Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Sanofi Main Business
Table 58. Sanofi Latest Developments
Table 59. Mitsubishi Tanabe Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 60. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 61. Mitsubishi Tanabe Pharma Main Business
Table 62. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Mitsubishi Tanabe Pharma Latest Developments
Table 64. Mylan Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 65. Mylan Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 66. Mylan Main Business
Table 67. Mylan Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Mylan Latest Developments
Table 69. Apotex Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 70. Apotex Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 71. Apotex Main Business
Table 72. Apotex Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Apotex Latest Developments
Table 74. Glemark Generics Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 75. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 76. Glemark Generics Main Business
Table 77. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Glemark Generics Latest Developments
Table 79. Sun Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 80. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 81. Sun Pharma Main Business
Table 82. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Sun Pharma Latest Developments
Table 84. Covis Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 85. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 86. Covis Pharma Main Business
Table 87. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Covis Pharma Latest Developments
Table 89. Lunan Pharma Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 90. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 91. Lunan Pharma Main Business
Table 92. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Lunan Pharma Latest Developments
Table 94. CSPC Pharmaceutical Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 95. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 96. CSPC Pharmaceutical Main Business
Table 97. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. CSPC Pharmaceutical Latest Developments
Table 99. Ascend Laboratories Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 100. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 101. Ascend Laboratories Main Business
Table 102. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Ascend Laboratories Latest Developments
Table 104. EISAI Details, Company Type, Amyotrophic Lateral Sclerosis Drugs Area Served and Its Competitors
Table 105. EISAI Amyotrophic Lateral Sclerosis Drugs Product Offered
Table 106. EISAI Amyotrophic Lateral Sclerosis Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. EISAI Main Business
Table 108. EISAI Latest Developments
LIST OF FIGURES
Figure 1. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Amyotrophic Lateral Sclerosis Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country/Region (2023)
Figure 8. Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type in 2023
Figure 10. Amyotrophic Lateral Sclerosis Drugs in Hospital Pharmacies
Figure 11. Global Amyotrophic Lateral Sclerosis Drugs Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Amyotrophic Lateral Sclerosis Drugs in Retail Pharmacies
Figure 13. Global Amyotrophic Lateral Sclerosis Drugs Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 14. Amyotrophic Lateral Sclerosis Drugs in Online Pharmacies
Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application in 2023
Figure 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Player in 2023
Figure 18. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Amyotrophic Lateral Sclerosis Drugs Value Market Share by Country in 2023
Figure 24. United States Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application in 2023
Figure 31. China Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Amyotrophic Lateral Sclerosis Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country/Region (2023)
Figure 8. Amyotrophic Lateral Sclerosis Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type in 2023
Figure 10. Amyotrophic Lateral Sclerosis Drugs in Hospital Pharmacies
Figure 11. Global Amyotrophic Lateral Sclerosis Drugs Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 12. Amyotrophic Lateral Sclerosis Drugs in Retail Pharmacies
Figure 13. Global Amyotrophic Lateral Sclerosis Drugs Market: Retail Pharmacies (2019-2024) & ($ Millions)
Figure 14. Amyotrophic Lateral Sclerosis Drugs in Online Pharmacies
Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market: Online Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application in 2023
Figure 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Player in 2023
Figure 18. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 20. APAC Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 21. Europe Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Americas Amyotrophic Lateral Sclerosis Drugs Value Market Share by Country in 2023
Figure 24. United States Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region in 2023
Figure 29. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type in 2023
Figure 30. APAC Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application in 2023
Figure 31. China Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Country in 2023
Figure 38. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Figure 39. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Figure 40. Germany Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Amyotrophic Lateral Sclerosis Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 54. APAC Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 55. Europe Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 57. United States Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Canada Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 61. China Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Japan Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 63. Korea Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 65. India Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Australia Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 67. Germany Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 68. France Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 69. UK Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Italy Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 71. Russia Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Spain Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Israel Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Amyotrophic Lateral Sclerosis Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Amyotrophic Lateral Sclerosis Drugs Market Size Market Share Forecast by Application (2025-2030)
